SBI Securities’s Chemomab Therapeutics CMMB Stock Holding History

SBI Securities’s Portfolio CMMB Stock Details CMMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$36	Sell	30 -4	-12%	-$8	﹤0.01%	3816
2026 Q2	$55	Buy	34 +6	+21%	+$10	﹤0.01%	3642
2026 Q1	$44	Buy	28 +2	+8%	+$3	﹤0.01%	3602
2025 Q4	$43	Hold	26	–	–	﹤0.01%	3603
2025 Q3	$68	Sell	26 -2	-7%	-$7	﹤0.01%	3626
2025 Q2	$129	Buy	28 +2	+8%	+$10	﹤0.01%	3454
2025 Q1	$113	Buy	26 +1	+4%	+$7	﹤0.01%	3402
2024 Q4	$181	Buy	+25	New	+$158	﹤0.01%	3274

Other funds holding CMMB

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities's CMMB Position: Q3 2026 in Review

SBI Securities reduced its Chemomab Therapeutics (CMMB) stake by 12% in Q3 2026, selling an estimated $8 and leaving 30 shares worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #3816.

SBI Securities first reported a position in CMMB in Q4 2024 and has held it in 8 quarters since. The position peaked at $181 in Q4 2024. 2 funds tracked by Wall St. Rank hold CMMB as of Q3 2026.

SBI Securities held 30 shares of Chemomab Therapeutics worth $36 as of Q3 2026.
SBI Securities sold 4 Chemomab Therapeutics shares in Q3 2026, an estimated $8.
Chemomab Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3816 holding.
SBI Securities first reported a position in Chemomab Therapeutics in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Chemomab Therapeutics position peaked at $181 in Q4 2024.
2 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.